Tag Archive for: diagnostics

The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market

Pharmacodiagnostics is swiftly emerging as a vital player in the global cancer diagnostics market, which soared to nearly $10 billion in revenue in 2024, according to Kalorama Information’s recent report, The World Market for Cancer Diagnostics, 2024-2029. This dynamic sub-segment is experiencing rapid growth, fueled by the increasing affordability of next-generation sequencing (NGS), which offers profound […]

IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing

This blog draws on insights from the Kalorama Information report, In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029. For further details, please visit the report’s product page HERE. Personalized medicine, also known as precision medicine, is revolutionizing the healthcare landscape. This innovative approach tailors medical treatment to the individual characteristics of […]

IVDBO: Blood Screening Diagnostics 2024 Market Insights

Welcome to our latest blog, created in collaboration with The Scott Partnership Ltd., a renowned UK-based global marketing and communications agency specializing in the life sciences, healthcare, and technology sectors. Originally published on their platform, this blog marks the beginning of an exciting ongoing partnership with more blogs to come. In Vitro Diagnostics Business Outlook’s […]

IVD Trends to Watch: The Evolution of Point-of-Care (POC) Diagnostic Testing

In 2023, point-of-care (POC) diagnostic testing market sales reached $36.8 billion, fueled by both professional and self-testing, according to Kalorama Information’s April 2024 report The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition. The POC diagnostic testing market continues to expand thanks to emerging technologies and increasing demand that will drive growth into the […]

Immunoassays: A $27 Billion Market of Intrigue and Opportunity

The global market for lab-based immunoassays, inclusive of both infectious disease and non-infectious disease analytes and instruments, reached $27 billion in 2023 and is forecast to experience modest growth in the foreseeable future. The findings are based on data published in In Vitro Diagnostics Business Outlook, 2024, a bi-monthly newsletter focused on global IVD products […]

IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth

In Egypt, like many other countries, the elderly population is growing rapidly, increasing at a rate of 5.1% annually, which is more than double the growth rate of the total population. This demographic shift, coupled with a large rural population requiring satellite care and mobile services, poses significant challenges for the healthcare system, according to […]

Cancer, Obesity, Diabetes, and Cardiovascular Disease Drive South Korea’s IVD Investment

South Korea ranks as the fifth largest health market in the Asia Pacific region, following China, Japan, Australia, and India.. South Korea’s investment in healthcare, medical devices, and diagnostics is driven by the burden of obesity, diabetes, cardiovascular disease, and cancer. The country’s business environment for medical devices and equipment is favorable and streamlined for […]

Personalized Medicine Key to IVD Procedure Volumes’ 10% Annual Growth

The in vitro diagnostic (IVD) industry is on track again after the disruptions of the pandemic. The overall volume of IVD procedures will rise steadily throughout most of the world, boosted by aging population trends, proliferating epidemiological patterns, increasing availability of healthcare funding, and widespread adoption of patient care strategies that emphasize early disease detection […]

How Globalization and Climate Change Impact COVID-19 and the IVD Market

COVID-19 hospitalizations in the U.S. have spiked in recent weeks amidst the advent of yet another new variant and the impending arrival of updated booster shots for a fall vaccination campaign. This late summer spike in infections comes after months of declines in COVID-related hospitalizations and deaths. The spike is poised to impact the in […]

China: Molecular Point-of-Care’s International Market to Watch

Molecular point-of-care (mPOC) is a multi-billion dollar market with expanding international intrigue. Though the mPOC market is led by North America and Europe, the Asia-Pacific region makes up 10% of the market’s worldwide sales, with China positioned as a burgeoning power within the APAC. Kalorama Information, a leading medical market research firm, covers mPOC’s global […]